{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:22:06Z","timestamp":1777418526782,"version":"3.51.4"},"reference-count":62,"publisher":"SAGE Publications","issue":"7-8","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2003,7]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To review the literature related to the treatment of alcohol dependence with acamprosate, a synthetic compound structurally similar to the naturally occurring amino acid, homotaurine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>Primary literature and review articles were identified by MEDLINE search (1966\u2013June 2003). Abstracts from recent meetings were also reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SYNTHESIS:<\/jats:title>\n                    <jats:p>Acamprosate has been marketed in 24 countries. Although the precise mechanism of acamprosate in the treatment of alcohol-dependent patients is unclear, it may restore the balance between inhibitory and excitatory neurotransmission in the central nervous system. European trials have shown consistent increases in abstinence rates compared with placebo when acamprosate use was paired with appropriate psychosocial and behavioral therapies. Decreased direct and indirect healthcare costs associated with acamprosate treatment have also been reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Acamprosate is a promising medication for the treatment of alcohol dependence in the US.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1345\/aph.1c351","type":"journal-article","created":{"date-parts":[[2003,6,23]],"date-time":"2003-06-23T11:29:53Z","timestamp":1056367793000},"page":"1090-1099","source":"Crossref","is-referenced-by-count":17,"title":["Acamprosate for the Adjunctive Treatment of Alcohol Dependence"],"prefix":"10.1177","volume":"37","author":[{"given":"Gerald P","family":"Overman","sequence":"first","affiliation":[{"name":"Gerald P Overman PharmD, Clinical Pharmacy Specialist for National Institute of Mental Health, Clinical Center Pharmacy Department, National Institutes of Health, Department of Health and Human Services, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian J","family":"Teter","sequence":"additional","affiliation":[{"name":"Christian J Teter PharmD, Post-Doctoral Fellow, College of Pharmacy, Substance Abuse Research Center, The University of Michigan, Ann Arbor, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally K","family":"Guthrie","sequence":"additional","affiliation":[{"name":"Sally K Guthrie PharmD, Associate Professor of Pharmacy, College of Pharmacy and Department of Psychiatry, The University of Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2003,7,1]]},"reference":[{"key":"bibr1-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.14.1318"},{"key":"bibr2-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199905133401907"},{"key":"bibr3-aph.1C351","first-page":"653","volume-title":"Martindale: the complete drug reference","author":"Sweetman SC","year":"2002","edition":"33"},{"key":"bibr4-aph.1C351","first-page":"785","volume":"30","author":"Chick J","year":"1995","journal-title":"Alcohol Alcohol"},{"key":"bibr5-aph.1C351","unstructured":"Acamprosate Summary Sheet, MTRAC, Department of Medicines Management, Keele University, Keele, Staffordshire, May 1997. www.ukmicentral.nhs.uk\/pressupp\/sd.asp (accessed 2002 Aug 1)."},{"key":"bibr6-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-80193-8_3"},{"key":"bibr7-aph.1C351","volume-title":"Pharmacotherapy for alcohol dependence: evidence report no. 3","author":"West SL","year":"1999"},{"key":"bibr8-aph.1C351","first-page":"S42","volume":"62","author":"Mason BJ","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"bibr9-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.alcalc.a045093"},{"key":"bibr10-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00176-8"},{"key":"bibr11-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(89)90005-1"},{"key":"bibr12-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1016\/0741-8329(87)90005-X"},{"key":"bibr13-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(92)90210-7"},{"key":"bibr14-aph.1C351","first-page":"119","volume":"14","author":"Gerra G","year":"1992","journal-title":"Neuroendocrinol Lett"},{"key":"bibr15-aph.1C351","first-page":"552","volume":"30","author":"Zieglgansberger W","year":"1995","journal-title":"Alcohol Alcohol"},{"key":"bibr16-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-80193-8_4"},{"key":"bibr17-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90682-8"},{"key":"bibr18-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4927(98)00016-X"},{"key":"bibr19-aph.1C351","first-page":"92A","volume":"20","author":"al Qatari M","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"bibr20-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1998.tb03872.x"},{"key":"bibr21-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1998.tb03636.x"},{"key":"bibr22-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)01272-4"},{"key":"bibr23-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979309"},{"key":"bibr24-aph.1C351","doi-asserted-by":"publisher","DOI":"10.15288\/jsa.1999.60.172"},{"key":"bibr25-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979334"},{"key":"bibr26-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199908000-00024"},{"key":"bibr27-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(99)80484-2"},{"key":"bibr28-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4927(98)00017-1"},{"key":"bibr29-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1159\/000026691"},{"key":"bibr30-aph.1C351","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199835050-00001"},{"key":"bibr31-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agg038"},{"key":"bibr32-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/36.5.413"},{"key":"bibr33-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/35.2.176"},{"key":"bibr34-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/35.2.202"},{"key":"bibr35-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1997.tb02873.x"},{"key":"bibr36-aph.1C351","first-page":"149","volume":"18","author":"Barrias JA","year":"1997","journal-title":"Psiquiatria Clinica"},{"key":"bibr37-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1159\/000259166"},{"key":"bibr38-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.171.1.73"},{"key":"bibr39-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91682-7"},{"key":"bibr40-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830080023006"},{"key":"bibr41-aph.1C351","first-page":"239","volume":"30","author":"Paille FM","year":"1995","journal-title":"Alcohol Alcohol"},{"key":"bibr42-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-2878-3_44"},{"key":"bibr43-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.alcalc.a045057"},{"key":"bibr44-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)91615-0"},{"key":"bibr45-aph.1C351","first-page":"1745","volume-title":"Psychopharmacology, the fourth generation of progress","author":"O'Brien CP","year":"1995"},{"key":"bibr46-aph.1C351","unstructured":"Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: American Psychiatric Association, 1980."},{"key":"bibr47-aph.1C351","unstructured":"Diagnostic and statistical manual of mental disorders. 3rd ed. revised. Washington, DC: American Psychiatric Association, 1987."},{"key":"bibr48-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1992.01820110045007"},{"key":"bibr49-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900012827"},{"key":"bibr50-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-003-0327-1"},{"key":"bibr51-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1998.tb04295.x"},{"key":"bibr52-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/36.5.419"},{"key":"bibr53-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.1.92"},{"key":"bibr54-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2001.tb02356.x"},{"issue":"27","key":"bibr55-aph.1C351","first-page":"1","volume":"14","year":"2002","journal-title":"Alcoholism Drug Abuse Wkly"},{"key":"bibr56-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(02)00368-8"},{"key":"bibr57-aph.1C351","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199813060-00008"},{"key":"bibr58-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/35.5.478"},{"key":"bibr59-aph.1C351","doi-asserted-by":"publisher","DOI":"10.1159\/000019013"},{"key":"bibr60-aph.1C351","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199916060-00010"},{"key":"bibr61-aph.1C351","unstructured":"Food and Drug Administration. Psychopharmacological Drugs Advisory Committee (5\/10\/02). NDA 21-431 Acamprosate 333 mg tablets (Lipha Pharmaceuticals, Inc.) www.fda.gov\/ohrms\/dockets\/ac\/02\/minutes\/3857M1.pdf (accessed 2002 Jul 18)."},{"issue":"19","key":"bibr62-aph.1C351","first-page":"24","volume":"64","year":"2002","journal-title":"FDA Pink Sheets"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1C351","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1345\/aph.1C351","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1C351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:07:15Z","timestamp":1777374435000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1345\/aph.1C351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":62,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["10.1345\/aph.1C351"],"URL":"https:\/\/doi.org\/10.1345\/aph.1c351","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7]]}}}